The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Qualigen Therapeutics, Inc(NASDAQ:QLGN) 
Qualigen, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system; ALAN, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; AS1411 for treating viral-...
Website: https://www.qualigeninc.com/
Founded: 1996
CEO: Andrew Ritter
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Qualigen Therapeutics Days Payable Outstanding ttm (DPO)
Qualigen Therapeutics Days Receivable Outstanding ttm (DSO)
Qualigen Therapeutics Days Inventory Outstanding ttm (DIO)
Qualigen Therapeutics Op Cashflow Per Share ttm
Qualigen Therapeutics Free Cashflow Per Share ttm
Qualigen Therapeutics Cash Per Share ttm
Qualigen Therapeutics P/S ratio ttm
Qualigen Therapeutics (GAAP) P/E ratio ttm
Qualigen Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.